Open Access · CC BY-NC 4.0
A Novel Role of Butaclamol as an Inhibitor of cGAS in Innate Immune Cells
Drug Targets and Therapeutics · 2024
DOI: 10.58502/dtt.23.0018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Targets and Therapeutics, 2024. Verfasst von Young Eun Yang und 2 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Research Foundation of Korea
- Ministry of Science and ICT
Zitieren
APA
Yang, Y. E., Seok, J. K., & Lee, J. Y. (2024). A Novel Role of Butaclamol as an Inhibitor of cGAS in Innate Immune Cells. Drug Targets and Therapeutics. https://doi.org/10.58502/dtt.23.0018
Vancouver
Yang YE, Seok JK, Lee JY. A Novel Role of Butaclamol as an Inhibitor of cGAS in Innate Immune Cells. Drug Targets and Therapeutics. 2024. doi:10.58502/dtt.23.0018
BibTeX
@article{Yang2024,
author = {Yang, Young Eun and Seok, Jin Kyung and Lee, Joo Young},
title = {A Novel Role of Butaclamol as an Inhibitor of cGAS in Innate Immune Cells},
journal = {Drug Targets and Therapeutics},
year = {2024},
doi = {10.58502/dtt.23.0018}
}
EUVIMED